OTCMKTS:ANTH - Anthera Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Anthera Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.03 0.00 (0.00 %) (As of 01/20/2020 04:00 PM ET) Add Compare Today's Range$0.02Now: $0.03▼$0.0350-Day Range$0.03MA: $0.03▼$0.0452-Week Range$0.02Now: $0.03▼$0.10Volume54,585 shsAverage Volume94,463 shsMarket Capitalization$730,422.00P/E RatioN/ADividend YieldN/ABeta3.87 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ANTH Previous Symbol CUSIPN/A CIK1316175 Webhttp://www.anthera.com/ Phone510-856-5600Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares26,180,000Market Cap$730,422.00 Next Earnings DateN/A OptionableOptionable Receive ANTH News and Ratings via Email Sign-up to receive the latest news and ratings for ANTH and its competitors with MarketBeat's FREE daily newsletter. OTC:ANTH Rates by TradingView Anthera Pharmaceuticals (OTCMKTS:ANTH) Frequently Asked Questions What is Anthera Pharmaceuticals' stock symbol? Anthera Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ANTH." When did Anthera Pharmaceuticals' stock split? How did Anthera Pharmaceuticals' stock split work? Anthera Pharmaceuticals shares reverse split on the morning of Monday, May 1st 2017. The 1-8 reverse split was announced on Friday, April 28th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 28th 2017. An investor that had 100 shares of Anthera Pharmaceuticals stock prior to the reverse split would have 13 shares after the split. How were Anthera Pharmaceuticals' earnings last quarter? Anthera Pharmaceuticals Inc (OTCMKTS:ANTH) released its quarterly earnings results on Monday, March, 5th. The biopharmaceutical company reported ($0.73) earnings per share for the quarter, beating the consensus estimate of ($0.82) by $0.09. View Anthera Pharmaceuticals' Earnings History. Has Anthera Pharmaceuticals been receiving favorable news coverage? Press coverage about ANTH stock has trended extremely negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Anthera Pharmaceuticals earned a coverage optimism score of -5.0 on InfoTrie's scale. They also assigned news articles about the biopharmaceutical company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Anthera Pharmaceuticals. Who are some of Anthera Pharmaceuticals' key competitors? Some companies that are related to Anthera Pharmaceuticals include Auris Medical (EARS), Midatech Pharma (MTP), THERAPIX BIOSCI/S (TRPX), Innovus Pharmaceuticals (INNV), Global Future City (FTCY), American Bio Medica (ABMC), Ritter Pharmaceuticals (RTTR), Boston Therapeutics (BTHE), Wize Pharma (WIZP), Innovus Pharmaceuticals (INNVD), Parnell Pharmaceuticals (PARNF), MOTIF BIO PLC/S (MTFB), Cotinga Pharmaceuticals (COTQF), Peak Pharmaceuticals (PKPH) and Capstone Therapeutics (CAPS). What other stocks do shareholders of Anthera Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Anthera Pharmaceuticals investors own include Ocular Therapeutix (OCUL), Synergy Pharmaceuticals (SGYP), Novavax (NVAX), Alibaba Group (BABA), Arena Pharmaceuticals (ARNA), Dynavax Technologies (DVAX), Amicus Therapeutics (FOLD), Inovio Pharmaceuticals (INO), Opko Health (OPK) and Sangamo Therapeutics (SGMO). Who are Anthera Pharmaceuticals' key executives? Anthera Pharmaceuticals' management team includes the folowing people: Mr. Paul F. Truex, Exec. Chairman (Age 49)Mr. John Craig Thompson, Pres, CEO & Director (Age 51)Dr. Renee Martin Ph.D., Sr. VP of Medical Sciences (Age 49)Dr. William R. Shanahan Jr., M.D., J.D., Chief Medical Officer & Sr. VP (Age 69)Ms. May Liu, Chief Accounting Officer, Sr. VP of Fin. & Admin. and Compliance Officer (Age 42) How do I buy shares of Anthera Pharmaceuticals? Shares of ANTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Anthera Pharmaceuticals' stock price today? One share of ANTH stock can currently be purchased for approximately $0.03. How big of a company is Anthera Pharmaceuticals? Anthera Pharmaceuticals has a market capitalization of $730,422.00. View Additional Information About Anthera Pharmaceuticals. What is Anthera Pharmaceuticals' official website? The official website for Anthera Pharmaceuticals is http://www.anthera.com/. How can I contact Anthera Pharmaceuticals? Anthera Pharmaceuticals' mailing address is 25801 INDUSTRIAL BOULEVARD SUITE B, HAYWARD CA, 94545. The biopharmaceutical company can be reached via phone at 510-856-5600. MarketBeat Community Rating for Anthera Pharmaceuticals (OTCMKTS ANTH)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 335 (Vote Outperform)Underperform Votes: 325 (Vote Underperform)Total Votes: 660MarketBeat's community ratings are surveys of what our community members think about Anthera Pharmaceuticals and other stocks. Vote "Outperform" if you believe ANTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANTH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/20/2020 by MarketBeat.com StaffFeatured Article: What is the S&P/TSX Index?
